Endocrine Journal
Online ISSN : 1348-4540
Print ISSN : 0918-8959
ISSN-L : 0918-8959
ORIGINALS
Expression of Toll-like Receptors in the Pancreas of Recent-onset Fulminant Type 1 Diabetes
Saeko SHIBASAKIAkihisa IMAGAWASisko TAURIAINENMorio IINOMaarit OIKARINENHitoshi ABIRUKeiji TAMAKIHiroaki SEINOKatsuhiro NISHIIzumi TAKASEYoshikatsu OKADASae UNOYuko MURASE-MISHIBAJungo TERASAKIHideichi MAKINOIichiro SHIMOMURAHeikki HYöTYToshiaki HANAFUSA
Author information
JOURNAL FREE ACCESS

2010 Volume 57 Issue 3 Pages 211-219

Details
Abstract

Fulminant type 1 diabetes, established in 2000, is defined as a novel subtype of diabetes mellitus that results from remarkably acute and almost complete destruction of pancreatic beta cells at the disease onset. In this study, we aimed to clarify the pathogenesis of fulminant type 1 diabetes with special reference to insulitis and viral infection. We examined pancreatic autopsy samples from three patients who had died soon after the onset of disease and analyzed these by immunohistochemistry and in situ-hybridization. The results were that both beta and alpha cell areas were significantly decreased in comparison with those of normal controls. Mean beta cell area of the patients just after the onset was only 0.00256 % while that of normal control was 1.745 %. Macrophages and T cells-but no natural killer cells-had infiltrated the islets and the exocrine pancreas. Although both of them had massively infiltrated, macrophages dominated islet infiltration and were detected in 92.6 % of the patients' islets. Toll-like receptor (TLR) 3, a sensor of viral components, was detected in 84.7± 7.0 % of T cells and 62.7± 32.3 % of macrophages (mean± SD) in all three patients. TLR7 and TLR9 were also detected in the pancreas of all three patients. Enterovirus RNA was detected in beta-cell positive islets in one of the three patients by in situ-hybridization. In conclusion, our results suggest that macrophage-dominated insulitis rather than T cell autoimmunity contributes to beta cell destruction in fulminant type 1 diabetes.

Content from these authors
© The Japan Endocrine Society
Previous article Next article
feedback
Top